Clinical trial Recruiting at 1 site Observational Ages 18 and up

Long-Term Results After Ab-interno Trabeculotomy for Glaucoma

Official title: Long-Term Clinical Results of Ab-Interno Trabeculotomy in Glaucoma Management

Run by Wuerzburg University Hospital · NCT07780916 · Data updated 2026-11-12

This study tests whether ab-interno trabeculotomy with the Trabectome can provide sustained intraocular pressure reduction in glaucoma patients who had the procedure between 2019 and 2021.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment200 (estimated)
SponsorWuerzburg University Hospital
Academic / other
Locations1 site (Würzburg, Bavaria)
StatusRecruiting
StartedDecember 3, 2025
Main results expectedNovember 1, 2026
Study endsFebruary 1, 2027
Registry record updatedAugust 25, 2026
Trial IDNCT07780916 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with a glaucoma diagnosis who had AIT with the Trabectome at University Hospital Würzburg between 2019 and 2021 and can consent to a one-time study visit.

Probably not a fit

Patients without ongoing intraocular pressure concerns or with factors limiting benefit from MIGS may not experience improvement.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a single-center observational study evaluating long-term outcomes after ab-interno trabeculotomy (AIT) using the Trabectome in glaucoma patients. It uses a retrospective pre-operative baseline with a prospective cross-sectional follow-up visit to assess intraocular pressure, visual acuity, anterior chamber angle, and optic nerve structure. Participants undergo about 30 minutes of assessments including IOP measurement, gonioscopy, slit-lamp exam, and OCT imaging, all within routine care. No additional follow-up beyond the single study visit is required.

Why it matters

Potential benefit: If successful, patients could experience sustained lowering of intraocular pressure and better glaucoma control over the years after AIT.

How similar studies have gone: Previous short-term studies show favorable results, but long-term, multi-year data are limited, making this investigation relatively novel in its duration.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Diagnosis of glaucoma
* Previous ab-interno trabeculotomy (AIT) using the Trabectome device performed at the Department of Ophthalmology, University Hospital Würzburg
* Surgery performed between 2019 and 2021
* Ability to provide written informed consent
* Age ≥ 18 years at time of surgery

Exclusion Criteria:

* Inability to attend the study visit
* Withdrawal of informed consent
* Insufficient medical records for pre-operative baseline data retrieval

Where it's running

  • University Hospital Würzburg
    Würzburg, Bavaria, Germany
    Recruiting

Study contacts

  • Principal investigator: Raoul Verma-Führing, Dr. — Wuerzburg University Hospital
  • Study coordinator: Raoul Verma-Führing, Dr.
  • Email: augenklinik@ukw.de
  • Phone: +49 931 20120458

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.